Short Interest in Vitamin Shoppe Inc (NYSE:VSI) Drops By 23.0%
Vitamin Shoppe Inc (NYSE:VSI) saw a significant decrease in short interest in the month of August. As of August 31st, there was short interest totalling 5,154,700 shares, a decrease of 23.0% from the July 31st total of 6,693,600 shares. Based on an average daily volume of 727,100 shares, the days-to-cover ratio is currently 7.1 days. Approximately 26.2% of the company’s stock are short sold.
A number of large investors have recently made changes to their positions in the business. VIEX Capital Advisors LLC grew its stake in Vitamin Shoppe by 1,496.9% in the 2nd quarter. VIEX Capital Advisors LLC now owns 2,198,449 shares of the specialty retailer’s stock valued at $8,662,000 after purchasing an additional 2,060,782 shares during the period. Vanguard Group Inc. grew its stake in Vitamin Shoppe by 5.3% in the 2nd quarter. Vanguard Group Inc. now owns 1,809,069 shares of the specialty retailer’s stock valued at $7,128,000 after purchasing an additional 91,493 shares during the period. Dimensional Fund Advisors LP grew its stake in Vitamin Shoppe by 2.6% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,694,849 shares of the specialty retailer’s stock valued at $8,034,000 after purchasing an additional 42,340 shares during the period. BlackRock Inc. grew its stake in Vitamin Shoppe by 2.0% in the 2nd quarter. BlackRock Inc. now owns 1,660,359 shares of the specialty retailer’s stock valued at $6,541,000 after purchasing an additional 32,267 shares during the period. Finally, FMR LLC grew its stake in Vitamin Shoppe by 0.7% in the 1st quarter. FMR LLC now owns 1,656,511 shares of the specialty retailer’s stock valued at $11,662,000 after purchasing an additional 10,900 shares during the period. Hedge funds and other institutional investors own 94.19% of the company’s stock.
Vitamin Shoppe stock traded down $0.16 during trading on Friday, hitting $7.20. 202,624 shares of the company were exchanged, compared to its average volume of 593,765. The business’s 50 day moving average is $5.86 and its 200 day moving average is $5.53. Vitamin Shoppe has a 52 week low of $3.32 and a 52 week high of $13.63. The company has a market capitalization of $170.85 million, a P/E ratio of 27.69 and a beta of 1.55. The company has a current ratio of 1.18, a quick ratio of 0.23 and a debt-to-equity ratio of 2.37.
A number of equities analysts have recently weighed in on the company. ValuEngine raised Vitamin Shoppe from a “sell” rating to a “hold” rating in a research report on Thursday, August 8th. Jefferies Financial Group began coverage on Vitamin Shoppe in a report on Monday, June 17th. They set a “hold” rating and a $4.00 price target for the company. Finally, Zacks Investment Research downgraded Vitamin Shoppe from a “buy” rating to a “hold” rating in a report on Thursday, August 15th. Five analysts have rated the stock with a hold rating, Vitamin Shoppe has a consensus rating of “Hold” and an average price target of $8.42.
Vitamin Shoppe Company Profile
Vitamin Shoppe, Inc, through its subsidiaries, operates as a omni-channel specialty retailer and contract manufacturer of nutritional products in the United States and internationally. It operates in two segments, Retail and Manufacturing. The company provides custom manufacturing and private labeling services for vitamin, mineral, and supplement products, as well as develops and markets own branded products.
Read More: What is the Bid-Ask Spread?
Receive News & Ratings for Vitamin Shoppe Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vitamin Shoppe and related companies with MarketBeat.com's FREE daily email newsletter.